Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Glycosylation of viral surface proteins probed by mass spectrometry.

Hargett AA, Renfrow MB.

Curr Opin Virol. 2019 Jun;36:56-66. doi: 10.1016/j.coviro.2019.05.003. Epub 2019 Jun 13. Review.

PMID:
31202133
2.

Glycosylation in health and disease.

Reily C, Stewart TJ, Renfrow MB, Novak J.

Nat Rev Nephrol. 2019 Jun;15(6):346-366. doi: 10.1038/s41581-019-0129-4. Review.

3.

Pyrazolopyrimidinones, a novel class of copper-dependent bactericidal antibiotics against multi-drug resistant S. aureus.

Crawford CL, Dalecki AG, Narmore WT, Hoff J, Hargett AA, Renfrow MB, Zhang M, Kalubowilage M, Bossmann SH, Queern SL, Lapi SE, Hunter RN, Bao D, Augelli-Szafran CE, Kutsch O, Wolschendorf F.

Metallomics. 2019 Apr 17;11(4):784-798. doi: 10.1039/c8mt00316e.

PMID:
30855050
4.

IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2.

Stewart TJ, Takahashi K, Whitaker RH, Raska M, Placzek WJ, Novak J, Renfrow MB.

Glycobiology. 2019 Jul 1;29(7):543-556. doi: 10.1093/glycob/cwz007.

PMID:
30759204
5.

Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols.

McDaniel JK, Abdelgawwad MS, Hargett A, Renfrow MB, Bdeir K, Cao W, Cines DB, Zheng XL.

J Thromb Haemost. 2019 Apr;17(4):596-606. doi: 10.1111/jth.14407. Epub 2019 Mar 13.

PMID:
30741476
6.

Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.

Hargett AA, Wei Q, Knoppova B, Hall S, Huang ZQ, Prakash A, Green TJ, Moldoveanu Z, Raska M, Novak J, Renfrow MB.

J Virol. 2018 Dec 10;93(1). pii: e01177-18. doi: 10.1128/JVI.01177-18. Print 2019 Jan 1.

7.

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

Novak J, Barratt J, Julian BA, Renfrow MB.

Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016. Review.

PMID:
30177018
8.

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.

Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.

PLoS One. 2018 Jan 11;13(1):e0190967. doi: 10.1371/journal.pone.0190967. eCollection 2018.

9.

Role of remodeling and spacing factor 1 in histone H2A ubiquitination-mediated gene silencing.

Zhang Z, Jones AE, Wu W, Kim J, Kang Y, Bi X, Gu Y, Popov IK, Renfrow MB, Vassylyeva MN, Vassylyev DG, Giles KE, Chen D, Kumar A, Fan Y, Tong Y, Liu CF, An W, Chang C, Luo J, Chow LT, Wang H.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7949-E7958. doi: 10.1073/pnas.1711158114. Epub 2017 Aug 30.

10.

Efficient, ultra-high-affinity chromatography in a one-step purification of complex proteins.

Vassylyeva MN, Klyuyev S, Vassylyev AD, Wesson H, Zhang Z, Renfrow MB, Wang H, Higgins NP, Chow LT, Vassylyev DG.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5138-E5147. doi: 10.1073/pnas.1704872114. Epub 2017 Jun 12.

11.

What insights can proteomics give us into IgA nephropathy (Berger's disease)?

Renfrow MB, Novak J.

Expert Rev Proteomics. 2017 Aug;14(8):645-647. doi: 10.1080/14789450.2017.1331738. Epub 2017 May 29. No abstract available.

PMID:
28535694
12.

Training in metabolomics research. II. Processing and statistical analysis of metabolomics data, metabolite identification, pathway analysis, applications of metabolomics and its future.

Barnes S, Benton HP, Casazza K, Cooper SJ, Cui X, Du X, Engler J, Kabarowski JH, Li S, Pathmasiri W, Prasain JK, Renfrow MB, Tiwari HK.

J Mass Spectrom. 2016 Aug;51(8):535-548. doi: 10.1002/jms.3780.

13.

Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy.

Huang ZQ, Raska M, Stewart TJ, Reily C, King RG, Crossman DK, Crowley MR, Hargett A, Zhang Z, Suzuki H, Hall S, Wyatt RJ, Julian BA, Renfrow MB, Gharavi AG, Novak J.

J Am Soc Nephrol. 2016 Nov;27(11):3278-3284. Epub 2016 Mar 10.

14.

Training in metabolomics research. I. Designing the experiment, collecting and extracting samples and generating metabolomics data.

Barnes S, Benton HP, Casazza K, Cooper SJ, Cui X, Du X, Engler JA, Kabarowski JH, Li S, Pathmasiri W, Prasain JK, Renfrow MB, Tiwari HK.

J Mass Spectrom. 2016 Jul;51(7):ii-iii. doi: 10.1002/jms.3672.

PMID:
27434812
15.

Training in metabolomics research. I. Designing the experiment, collecting and extracting samples and generating metabolomics data.

Barnes S, Benton HP, Casazza K, Cooper SJ, Cui X, Du X, Engler J, Kabarowski JH, Li S, Pathmasiri W, Prasain JK, Renfrow MB, Tiwari HK.

J Mass Spectrom. 2016 Jul;51(7):461-75. doi: 10.1002/jms.3782.

16.

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Knoppova B, Reily C, Maillard N, Rizk DV, Moldoveanu Z, Mestecky J, Raska M, Renfrow MB, Julian BA, Novak J.

Front Immunol. 2016 Apr 12;7:117. doi: 10.3389/fimmu.2016.00117. eCollection 2016. Review.

17.

General N-and O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of Exogenous Oligosaccharide.

Daubenspeck JM, Jordan DS, Simmons W, Renfrow MB, Dybvig K.

PLoS One. 2015 Nov 23;10(11):e0143362. doi: 10.1371/journal.pone.0143362. eCollection 2015.

18.

New Insights into the Pathogenesis of IgA Nephropathy.

Novak J, Rizk D, Takahashi K, Zhang X, Bian Q, Ueda H, Ueda Y, Reily C, Lai LY, Hao C, Novak L, Huang ZQ, Renfrow MB, Suzuki H, Julian BA.

Kidney Dis (Basel). 2015 May;1(1):8-18. Epub 2015 May 1.

19.

The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.

Tao J, Kang KD, Hall SD, Laube AH, Liu J, Renfrow MB, Novak J, Luo G.

J Virol. 2015 Jul;89(13):6782-91. doi: 10.1128/JVI.00194-15. Epub 2015 Apr 22.

20.

Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.

Wall SB, Oh JY, Mitchell L, Laube AH, Campbell SL, Renfrow MB, Landar A.

Redox Biol. 2015;4:346-54. doi: 10.1016/j.redox.2015.01.016. Epub 2015 Feb 3.

21.

N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.

Stuchlova Horynova M, Vrablikova A, Stewart TJ, Takahashi K, Czernekova L, Yamada K, Suzuki H, Julian BA, Renfrow MB, Novak J, Raska M.

Nephrol Dial Transplant. 2015 Feb;30(2):234-8. doi: 10.1093/ndt/gfu308. Epub 2014 Oct 3.

22.

Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.

Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J.

PLoS One. 2014 Jun 11;9(2):e99026. doi: 10.1371/journal.pone.0099026. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113577.

23.

Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling.

Jones CM, Wells RM, Madduri AV, Renfrow MB, Ratledge C, Moody DB, Niederweis M.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1945-50. doi: 10.1073/pnas.1311402111. Epub 2014 Jan 13.

24.

Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.

Boerma LJ, Xia G, Qui C, Cox BD, Chalmers MJ, Smith CD, Lobo-Ruppert S, Griffin PR, Muccio DD, Renfrow MB.

J Biol Chem. 2014 Jan 10;289(2):814-26. doi: 10.1074/jbc.M113.476861. Epub 2013 Nov 1.

25.

Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J, Wyatt RJ.

Expert Opin Med Diagn. 2013 Nov;7(6):615-27. doi: 10.1517/17530059.2013.856878. Review.

26.

O-linked protein glycosylation in Mycoplasma.

Jordan DS, Daubenspeck JM, Laube AH, Renfrow MB, Dybvig K.

Mol Microbiol. 2013 Dec;90(5):1046-53. doi: 10.1111/mmi.12415. Epub 2013 Oct 18.

27.

Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.

Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.

J Proteomics. 2013 Oct 30;92:299-312. doi: 10.1016/j.jprot.2013.07.013. Epub 2013 Jul 24.

28.

Pathogenesis of immunoglobulin A nephropathy.

Novak J, Renfrow MB, Gharavi AG, Julian BA.

Curr Opin Nephrol Hypertens. 2013 May;22(3):287-94. doi: 10.1097/MNH.0b013e32835fef54. Review.

PMID:
23511518
29.

IgA nephropathy: molecular mechanisms of the disease.

Mestecky J, Raska M, Julian BA, Gharavi AG, Renfrow MB, Moldoveanu Z, Novak L, Matousovic K, Novak J.

Annu Rev Pathol. 2013 Jan 24;8:217-40. doi: 10.1146/annurev-pathol-011110-130216. Epub 2012 Oct 18. Review.

PMID:
23092188
30.

Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Novak J, Julian BA, Mestecky J, Renfrow MB.

Semin Immunopathol. 2012 May;34(3):365-82. doi: 10.1007/s00281-012-0306-z. Epub 2012 Mar 21. Review.

PMID:
22434325
31.

SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency.

Lai YS, Chang CW, Pawlik KM, Zhou D, Renfrow MB, Townes TM.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3772-7. doi: 10.1073/pnas.1108595109. Epub 2012 Feb 23.

32.

Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, Mestecky J, Novak J, Renfrow MB.

J Proteome Res. 2012 Feb 3;11(2):692-702. doi: 10.1021/pr200608q. Epub 2011 Dec 29.

33.

Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells.

Horynová M, Takahashi K, Hall S, Renfrow MB, Novak J, Raška M.

Protein Expr Purif. 2012 Feb;81(2):175-80. doi: 10.1016/j.pep.2011.10.006. Epub 2011 Oct 19.

34.

The pathophysiology of IgA nephropathy.

Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA.

J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23. Review.

35.

Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities.

Webber PJ, Smith AD, Sen S, Renfrow MB, Mobley JA, West AB.

J Mol Biol. 2011 Sep 9;412(1):94-110. doi: 10.1016/j.jmb.2011.07.033. Epub 2011 Jul 22.

36.

Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46.

Joo HY, Jones A, Yang C, Zhai L, Smith AD 4th, Zhang Z, Chandrasekharan MB, Sun ZW, Renfrow MB, Wang Y, Chang C, Wang H.

J Biol Chem. 2011 Mar 4;286(9):7190-201. doi: 10.1074/jbc.M110.158311. Epub 2010 Dec 23.

37.

Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.

Xia G, Boerma LJ, Cox BD, Qiu C, Kang S, Smith CD, Renfrow MB, Muccio DD.

Biochemistry. 2011 Jan 11;50(1):93-105. Epub 2010 Dec 8.

38.

Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.

Takahashi K, Wall SB, Suzuki H, Smith AD 4th, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB.

Mol Cell Proteomics. 2010 Nov;9(11):2545-57. doi: 10.1074/mcp.M110.001834. Epub 2010 Sep 7.

39.

Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.

Raska M, Takahashi K, Czernekova L, Zachova K, Hall S, Moldoveanu Z, Elliott MC, Wilson L, Brown R, Jancova D, Barnes S, Vrbkova J, Tomana M, Smith PD, Mestecky J, Renfrow MB, Novak J.

J Biol Chem. 2010 Jul 2;285(27):20860-9. doi: 10.1074/jbc.M109.085472. Epub 2010 May 3.

40.

Tissue localization and solubilities of αA-crystallin and its numerous C-terminal truncation products in pre- and postcataractous ICR/f rat lenses.

Stella DR, Floyd KA, Grey AC, Renfrow MB, Schey KL, Barnes S.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5153-61. doi: 10.1167/iovs.10-5302. Epub 2010 Apr 30.

41.

The RNA polymerase-associated factor 1 complex (Paf1C) directly increases the elongation rate of RNA polymerase I and is required for efficient regulation of rRNA synthesis.

Zhang Y, Smith AD 4th, Renfrow MB, Schneider DA.

J Biol Chem. 2010 May 7;285(19):14152-9. doi: 10.1074/jbc.M110.115220. Epub 2010 Mar 18.

42.

Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1.

Wada Y, Dell A, Haslam SM, Tissot B, Canis K, Azadi P, Bäckström M, Costello CE, Hansson GC, Hiki Y, Ishihara M, Ito H, Kakehi K, Karlsson N, Hayes CE, Kato K, Kawasaki N, Khoo KH, Kobayashi K, Kolarich D, Kondo A, Lebrilla C, Nakano M, Narimatsu H, Novak J, Novotny MV, Ohno E, Packer NH, Palaima E, Renfrow MB, Tajiri M, Thomsson KA, Yagi H, Yu SY, Taniguchi N.

Mol Cell Proteomics. 2010 Apr;9(4):719-27. doi: 10.1074/mcp.M900450-MCP200. Epub 2009 Dec 28.

43.

Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response.

Singh A, Crossman DK, Mai D, Guidry L, Voskuil MI, Renfrow MB, Steyn AJ.

PLoS Pathog. 2009 Aug;5(8):e1000545. doi: 10.1371/journal.ppat.1000545. Epub 2009 Aug 14.

44.

Drosophila Orc6 facilitates GTPase activity and filament formation of the septin complex.

Huijbregts RP, Svitin A, Stinnett MW, Renfrow MB, Chesnokov I.

Mol Biol Cell. 2009 Jan;20(1):270-81. doi: 10.1091/mbc.E08-07-0754. Epub 2008 Nov 5.

45.

Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Gomes MM, Wall SB, Takahashi K, Novak J, Renfrow MB, Herr AB.

Biochemistry. 2008 Oct 28;47(43):11285-99. doi: 10.1021/bi801185b. Epub 2008 Oct 1.

46.

High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Barnes S, Shonsey EM, Eliuk SM, Stella D, Barrett K, Srivastava OP, Kim H, Renfrow MB.

Biochem Soc Trans. 2008 Oct;36(Pt 5):1037-44. doi: 10.1042/BST0361037.

47.

Probing conserved helical modules of portal complexes by mass spectrometry-based hydrogen/deuterium exchange.

Kang S, Poliakov A, Sexton J, Renfrow MB, Prevelige PE Jr.

J Mol Biol. 2008 Sep 5;381(3):772-84. doi: 10.1016/j.jmb.2008.03.004. Epub 2008 Mar 18.

48.

SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation.

Isbell TS, Sun CW, Wu LC, Teng X, Vitturi DA, Branch BG, Kevil CG, Peng N, Wyss JM, Ambalavanan N, Schwiebert L, Ren J, Pawlik KM, Renfrow MB, Patel RP, Townes TM.

Nat Med. 2008 Jul;14(7):773-7. doi: 10.1038/nm1771. Epub 2008 May 30.

49.

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.

Kidney Blood Press Res. 2008;31(1):29-37. doi: 10.1159/000112922. Epub 2008 Jan 8. Review.

50.

Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.

Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB, Chen YF.

Circ Res. 2008 Feb 1;102(2):185-92. Epub 2007 Nov 8.

PMID:
17991884

Supplemental Content

Loading ...
Support Center